magnesium molecular entities
|
25108 |
|
(5Z,13E)-(15S)-11alpha,15-dihydroxy-9-oxoprost-13-enoate:NAD(+) 15-oxidoreductase inhibitor
|
77108 |
|
(5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprost-5,13-dienoate:NAD(+) 15-oxidoreductase inhibitor
|
77108 |
|
11alpha,15-dihydroxy-9-oxoprost-13-enoate:NAD(+) 15-oxidoreductase inhibitor
|
77108 |
|
15-hydroxyprostaglandin dehydrogenase inhibitor
|
77108 |
|
15-hydroxyprostanoic dehydrogenase inhibitor
|
77108 |
|
prostaglandin dehydrogenase inhibitor
|
77108 |
|
lipopolysaccharide biosynthesis inhibitors
|
134108 |
|
(5Z,13E)-(15S)-11alpha,15-dihydroxy-9-oxoprost-13-enoate:NAD(+) 15-oxidoreductase inhibitors
|
77108 |
|
(5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprost-5,13-dienoate:NAD(+) 15-oxidoreductase inhibitors
|
77108 |
|
11alpha,15-dihydroxy-9-oxoprost-13-enoate:NAD(+) 15-oxidoreductase inhibitors
|
77108 |
|
15-hydroxyprostaglandin dehydrogenase inhibitors
|
77108 |
|
15-hydroxyprostanoic dehydrogenase inhibitors
|
77108 |
|